Sublingual misoprostol to reduce blood loss at cesarean delivery
Phase 4
- Conditions
- postpartum hemorrhage.Haemorrhage after delivery of fetus or infant
- Registration Number
- IRCT2016030126857N1
- Lead Sponsor
- Vice President of Research of mashhad university of medical science
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Complete
- Sex
- Female
- Target Recruitment
- 90
Inclusion Criteria
inclusion criteria: the term pregnant women with risk factor for post partum hemorrhage such as uterine overdistention (multifetal gestatation.macrosomia), arrest disorder, prolonged induction and prolonged preterm rupture of membrane
exclusion criteria: Lack of consent, coagulation disorders , Anemia, Intraabdominal adhesion, Intraoperative bladder and intestines and other viscera damage, Abnormal adhesion of placenta, extended Uterine incision during cesarean delivery and known hypersensitivity to misoprostol.
Exclusion Criteria
Not provided
Study & Design
- Study Type
- interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method Mean estimate blood loss. Timepoint: During surgery. Method of measurement: Milliliter.
- Secondary Outcome Measures
Name Time Method Adverse effect. Timepoint: In the first day after surgery. Method of measurement: presence or absence.